1Cicoira M,Zanolla L,Rossi A,et al.Failure of aldosterone suppression despite angiotensin-converting enzyme inhibitor(ACEI) administration in chronic heart failure is associated with ACE DD genotype[J].J Am Coll Cardiol,2001,37(7):1808-1812.
2The RALES Investigators.Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe congestive heart failure (the randomized aldactone evaluation study RALES)[J].Am J Cardiol,1996,78(8):902-907.
3Blacher J,Amah G,Girerd X,et al.Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension[J].Am J Hypertens,1997,10(12 pt 1):1326-1334.
4Clrata H,Hoffmann S,Ganten D.Tissue angiotensin II system in the human heart[J].Eur Heart J,1994,15:68-78.
5Steassen J,Lijnen P,Fagard LJ,et al.Rise in plasma concentration of aldosterone during long-term angiotension II suppression[J].J Endocrinol,1981,91:457.
6Dzau VJ,Hirsch A.Emerging role of tissue renin-angiotensin systems in congestive heart failure[J].Eur heart J,1990,11:65-71.
7Urata H,Strobel F,Ganten D.Widespread tissue distribution of human chymase[J].J Hypertens,1994,12(suppl):S17-22.
8Lee AF,Mac Fadyen RJ,Struthera AD.Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy; a longiyudinal study[J].Eur J Heart Fail,1999,1(4):401-406.
9Richards M,Nicholls G.Aldosterone antagonism in heart failure[J].Lancet,1999,1354(9):789.
10Duprez DA,Bauwens FR,Debuyzere ML,et al.Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension[J].Am J Cardiol,1993,71(3):17A-20A.
